This announcement is a separate document:
华仁药业:董事会对独董独立性评估的专项意见
Huaren Pharmaceutical: Special opinion of the board of directors on the sole director's independence assessment
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.